MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets

Blood

Volumn 95, Issue 8, 2000, Pages 2666-2671

  Dyomin, Vadim G ^a   Palanisamy, Nallasivam ^a   Lloyd, Kenneth O ^a   Dyomina, Katerina ^a   Jhanwar, Suresh C ^a   Houldsworth, Jane ^a   Chaganti, R S K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MUCIN 1; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CHROMOSOME 1Q; CHROMOSOME TRANSLOCATION 1; CONTROLLED STUDY; DNA PROBE; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034655650     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.8.2666.008k02_2666_2671     Document Type: Article

References (33)

1. Chaganti RSK, Balazs I, Jhanwar SC, et al. The cellular homologue of the transforming gene of SKV avian retrovirus maps to human chromosome region 1q22-q24. Cylogenet Cell Genet. 1986;43:181-186.
2. Cigudosa JC, Parsa NZ, Louie DC, et al. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer. 1999;25:123-133.
3. Tilly H, Rossi A, Stamatoullas A, et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood. 1994;15:1043-1049.
4. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet. 1997;15: 417-474.
5. Willis TG, Zalcberg IR, Coignet LJ. et al. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood. 1998;91:1873-1881.
6. Chaganti RSK. New insights into the genetics of non-Hodgkin's lymphoma. Int Proc J. 1998;5: 34-41.
7. Croce MV, Colussi AG, Price MR, Segal-Eiras A. Expression of tumour associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative immunohistochemical study. Anticancer Res. 1997;17:4287-4292.
8. Dong Y, Walsh MD, Cummings MC, et al. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. J Pathol. 1997;183:311-317.
9. Nakagawa K, Akagi J, Takai E, et al. Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma. Int J Oncol. 1999;14:425-435.
10. Tanimoto T, Tanaka S, Haruma K, et al. MUC1 expression in intramucosal colorectal neoplasms: possible involvement in histogenesis and progression. Oncology. 1999;56:223-231.
11. Chang H, Blondal JA, Benchimol S, Minden MD, Messner HA. p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines. Leuk Lymphoma. 1995;19:165-171.
12. Rao PH, Murty VV, Gaidano G, Hauptschein R, Dalla-Favera R, Chaganti RSK. Subregional localization of 20 single-copy loci to chromosome 6 by fluorescence in situ hybridization. Genomics. 1993;16:426-430.
13. Chaganti SR, Rao PH, Chen W, et al. Deregulation of BCL6 in non-Hodgkin lymphoma by insertion of IGH sequences in complex translocations involving band 3q27. Genes Chromosomes Cancer. 1998;23:328-336.
14. Houldsworth J, Mathew S, Rao PH, et al. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood. 1996; 87:25-29.
15. Houldsworth J, Reuter V, Bosl GJ, Chaganti RSK. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ. 1997;8:293-299.
16. Oosterkamp HM, Scheiner L, Stefanova MC, Lloyd KO, Finstad CL. Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z). Int J Cancer. 1997; 72:87-94.
17. Dyomin VG, Rao PH, Dalla-Favera R, Chaganti RSK. BCL8, a novel gene involved in translocations affecting band 15q11-13 in diffuse large-cell lymphoma. Proc Natl Acad Sci U S A. 1997;94: 5728-5732.
18. Gordon CM, Lloyd KO. Endocytosis and recycling of gangliosides in a human melanoma cell line: inhibitory effect of brefeldin A and monensin. Arch Biochem Biophys. 1994;315:339-344.
19. Taylor-Papadimitriou J. Report on the first international workshop on carcinoma-associated mucins. Int J Cancer. 1991;49:1-5.
20. Winfield SL, Tayebi N, Martin BM, Ginns EI, Sidransky E. Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher's disease. Genome Res. 1997;7:1020-1026.
21. Ligtenberg MJ, Vos HL, Gennissen AM, Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J Biol Chem. 1990;265:5573-5578.
22. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem. 1990;265:15,286-15,293.
23. Treon SP, Mollick JA, Urashima M, et al. Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone. Blood. 1999;93:1287-1298.
24. Zrihan-Licht S, Vos HL, Baruch A, et al. Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue. Eur J Biochem. 1994;224:787-795.
25. Takahashi T, Makiguchi Y, Hinoda Y, et al. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from multiple myeloma patient. J Immunol. 1994;153: 2102-2109.
26. Spicer AP, Rowse GJ, Lidner TK, Gendler SJ. Delayed mammary tumor progression in Muc-1 null mice. J Biol Chem. 1995;270:30,093-30,101.
27. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol. 1995;129:255-265.
28. Agrawal B, Krantz MJ, Reddish MA, Longenecker BM. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat Med. 1998;4:43-49.
29. Baruch A, Hartmann M, Yoeli M, et al. The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein. Cancer Res. 1999;59:1552-1561.
30. Bieche I, Lidereau R. A gene dosage effect is responsible for high overexpression of the MUC1 gene observed in human breast tumors. Cancer Genet Cytogenet. 1997;98:75-80.
31. Kovarik A, Lu PJ, Peat N, Morris J, Taylor-Papadimitriou J. Two GC boxes (Sp1 sites) are involved in regulation of the activity of the epithelium-specific MUC1 promoter. J Biol Chem. 1996; 271:18,140-18,147.
32. Agrawal B, Gendler SJ, Longenecker BM. The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy. Mol Med Today. 1998;4:397-403.
33. Zhang S, Graeber LA, Helling F, et al. Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice. Cancer Res. 1996;56: 3315-3319.